Colfax (NYSE:CFX) recently announced that its planned standalone ortho device company will be called Enovis. “Enovis symbolizes the powerful combination of innovation and vision fueled by our passion for continuous improvement and reinforced by our drive to deliver superior clinical outcomes,” Colfax CEO Matt Trerotola said during a November 4 earnings call, transcribed by The […]
